DIRECT DIGITAL HOLDINGS IN-A (DRCT) Stock Fundamental Analysis

NASDAQ:DRCT • US25461T2042

1.09 USD
+0.17 (+18.48%)
At close: Feb 27, 2026
1.01 USD
-0.08 (-7.34%)
After Hours: 2/27/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, DRCT scores 1 out of 10 in our fundamental rating. DRCT was compared to 91 industry peers in the Media industry. Both the profitability and financial health of DRCT have multiple concerns. DRCT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • DRCT had negative earnings in the past year.
  • DRCT had a negative operating cash flow in the past year.
  • DRCT had negative earnings in 4 of the past 5 years.
  • In multiple years DRCT reported negative operating cash flow during the last 5 years.
DRCT Yearly Net Income VS EBIT VS OCF VS FCFDRCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • DRCT's Return On Assets of -42.00% is on the low side compared to the rest of the industry. DRCT is outperformed by 79.12% of its industry peers.
Industry RankSector Rank
ROA -42%
ROE N/A
ROIC N/A
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DRCT Yearly ROA, ROE, ROICDRCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 400 -400

1.3 Margins

  • Looking at the Gross Margin, with a value of 31.43%, DRCT is in line with its industry, outperforming 40.66% of the companies in the same industry.
  • In the last couple of years the Gross Margin of DRCT has declined.
  • DRCT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
DRCT Yearly Profit, Operating, Gross MarginsDRCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. Health

2.1 Basic Checks

  • DRCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DRCT has been increased compared to 1 year ago.
  • Compared to 1 year ago, DRCT has a worse debt to assets ratio.
DRCT Yearly Shares OutstandingDRCT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DRCT Yearly Total Debt VS Total AssetsDRCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • DRCT has an Altman-Z score of -2.18. This is a bad value and indicates that DRCT is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of DRCT (-2.18) is worse than 74.73% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.18
ROIC/WACCN/A
WACC10.63%
DRCT Yearly LT Debt VS Equity VS FCFDRCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • DRCT has a Current Ratio of 0.37. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DRCT has a Current ratio of 0.37. This is amonst the worse of the industry: DRCT underperforms 84.62% of its industry peers.
  • DRCT has a Quick Ratio of 0.37. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.37, DRCT is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
DRCT Yearly Current Assets VS Current LiabilitesDRCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • DRCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1762.87%.
  • Looking at the last year, DRCT shows a very negative growth in Revenue. The Revenue has decreased by -62.46% in the last year.
  • The Revenue has been growing by 17.76% on average over the past years. This is quite good.
EPS 1Y (TTM)-1762.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-534.62%
Revenue 1Y (TTM)-62.46%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-12.02%

3.2 Future

  • DRCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.33% yearly.
  • DRCT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.39% yearly.
EPS Next Y-1659.23%
EPS Next 2Y34.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-49.24%
Revenue Next 2Y-10.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DRCT Yearly Revenue VS EstimatesDRCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
DRCT Yearly EPS VS EstimatesDRCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 20 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DRCT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRCT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRCT Price Earnings VS Forward Price EarningsDRCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRCT Per share dataDRCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • DRCT's earnings are expected to grow with 34.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.33%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for DRCT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DIRECT DIGITAL HOLDINGS IN-A

NASDAQ:DRCT (2/27/2026, 8:00:02 PM)

After market: 1.01 -0.08 (-7.34%)

1.09

+0.17 (+18.48%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-06
Earnings (Next)03-25
Inst Owners0.99%
Inst Owner Change164.23%
Ins Owners0.89%
Ins Owner Change0%
Market Cap1.57M
Revenue(TTM)35.37M
Net Income(TTM)-9.46M
Analysts80
Price Target112.2 (10193.58%)
Short Float %7.79%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-707.56%
Min EPS beat(2)-1468.63%
Max EPS beat(2)53.51%
EPS beat(4)1
Avg EPS beat(4)-2044.59%
Min EPS beat(4)-6762.75%
Max EPS beat(4)53.51%
EPS beat(8)1
Avg EPS beat(8)-1272.49%
EPS beat(12)2
Avg EPS beat(12)-831.71%
EPS beat(16)5
Avg EPS beat(16)-613.34%
Revenue beat(2)0
Avg Revenue beat(2)-40.4%
Min Revenue beat(2)-64.81%
Max Revenue beat(2)-15.98%
Revenue beat(4)0
Avg Revenue beat(4)-32.8%
Min Revenue beat(4)-64.81%
Max Revenue beat(4)-14.88%
Revenue beat(8)0
Avg Revenue beat(8)-38.81%
Revenue beat(12)4
Avg Revenue beat(12)-16.24%
Revenue beat(16)6
Avg Revenue beat(16)-7.36%
PT rev (1m)0%
PT rev (3m)5400%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-29433.3%
EPS NY rev (1m)0%
EPS NY rev (3m)-14247.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-55.84%
Revenue NY rev (1m)-20.72%
Revenue NY rev (3m)-52.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-45.51
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-5.99
FCFYN/A
OCF(TTM)-5.96
OCFYN/A
SpS24.56
BVpS-0.81
TBVpS-11.08
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -42%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.43%
FCFM N/A
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
F-Score3
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.7%
Cap/Sales 0.11%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z -2.18
F-Score3
WACC10.63%
ROIC/WACCN/A
Cap/Depr(3y)14.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1762.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-534.62%
EPS Next Y-1659.23%
EPS Next 2Y34.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-62.46%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-12.02%
Revenue Next Year-49.24%
Revenue Next 2Y-10.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-435.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-352.53%
OCF growth 3YN/A
OCF growth 5YN/A

DIRECT DIGITAL HOLDINGS IN-A / DRCT FAQ

What is the fundamental rating for DRCT stock?

ChartMill assigns a fundamental rating of 1 / 10 to DRCT.


What is the valuation status of DIRECT DIGITAL HOLDINGS IN-A (DRCT) stock?

ChartMill assigns a valuation rating of 1 / 10 to DIRECT DIGITAL HOLDINGS IN-A (DRCT). This can be considered as Overvalued.


What is the profitability of DRCT stock?

DIRECT DIGITAL HOLDINGS IN-A (DRCT) has a profitability rating of 1 / 10.


Can you provide the financial health for DRCT stock?

The financial health rating of DIRECT DIGITAL HOLDINGS IN-A (DRCT) is 0 / 10.